[Ed. – It’s come to this.]
Snopes fact-checked a New York Times article that argued that President Donald Trump could stand to benefit financially from hydroxychloroquine being used to treat coronavirus patients, deeming the article “mostly false.”
The New York Times published an article Tuesday mentioning the president’s small financial stake Sanofi, a French pharmaceutical company that produces the anti-malaria drug that has shown to be effective in treating the virus. Trump’s personal stake in the company is estimated to be as small as $99. The president’s net worth is estimated to be between 3 and $4 billion.
“Because Trump’s financial interest in Sanofi and other pharmaceutical companies is indirect and minor, and because hydroxychloroquine is an easily produced generic drug unlikely to drive profit, we rank the claim that his promotion of the drug could lead to potential financial benefits as ‘Mostly false,’” the left-leaning fact check outlet wrote.